---
title: "LEPREL1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# LEPREL1 Gene"
tags: ['LEPREL1', 'PLOD1', 'CollagenBiosynthesis', 'EhlersDanlosSyndrome', 'SomaticMutations', 'TreatmentOptions', 'Prognosis', 'GeneticEpidemiology']
---

# LEPREL1 Gene

## Information

- **Genetic Position:** Chromosome 1 (from base pair 172,003,120 to 172,143,530)
- **Function for Gene:** Encodes for Procollagen Lysine 2-Oxoglutarate 5-Dioxygenase 1 (PLOD1) enzyme which catalyzes the hydroxylation of lysine residues in collagen and plays a role in collagen biosynthesis.

## External IDs, Aliases and Genomic Locations

- **HGNC ID:** HGNC:6672
- **NCBI Entrez Gene ID:** 54784
- **Ensembl Gene ID:** ENSG00000116761
- **OMIM ID:** 153454
- **UniProtKB/Swiss-Prot ID:** Q6A162
- **Aliases:** PLOD, LLH, LH1, LH2, LH3, PLOD1, FKSG36.

## List of AA Mutation Types with dbSNP ID

- c.1334G>C (p.Arg445Pro) rs141179609
- c.769G>A (p.Asp257Asn) rs145235492
- c.1280G>A (p.Arg427Gln) rs142637516

## Somatic SNVs/InDels with dbSNP ID

- rs144042334 - NM_016228.4(LEPREL1):c.1405G>A (p.Arg469His) - Somatic mutation in Calcaneal Osteosarcoma (COS) 
- rs148515871 - NM_001330521.1(LEPREL1):c.352C>T (p.Thr118Ile) - Somatic mutation in Non-Small Cell Lung Cancer (NSCLC)
- rs1554084017 - NM_001330521.1(LEPREL1):c.251C>T (p.Ala84Val) - Somatic mutation in Non-Small Cell Lung Cancer (NSCLC)


## Related Diseases

- Ehlers-Danlos Syndrome Type VI - A rare disease caused by a deficiency in PLOD1 enzyme activity leading to altered collagen crosslinking and abnormal collagen integrity.

## Treatment and Prognosis

- There is no cure for Ehlers-Danlos Syndrome Type VI, but supportive treatment options exist, including physical therapy, rehabilitation services, and surgical interventions. 
- The prognosis depends on the severity of symptoms and complications.

## Drug Response

- Currently, there are no specific drugs or treatments available for Ehlers-Danlos Syndrome Type VI. 

## References

- Lindahl K, Astrom E, Rubin CJ, et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015;23(8):1042-1050. doi:10.1038/ejhg.2014.225
- Champeaux C, Francannet C, Zhang X, et al. Ehlers-Danlos syndrome type VII C and VI: Primary cause of divergent clinical inherited phenotypes of PLOD1 mutations. Am J Med Genet A. 2017;173(5):1330-1335. doi:10.1002/ajmg.a.38155

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**